← Open Payments lookup

ANN MARIE RUSTIA: Open Payments

NPI 1992039622 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,100 in 56 payments from 19 companies in 2025. Trend: 2023 $1,376 · 2024 $823 · 2025 $1,100

Food & beverage: $1,100
CompanyPaymentsAmount
Astellas Pharma US Inc9$150
Amgen Inc.5$91
Novo Nordisk Inc5$90
ABBVIE INC.4$89
AstraZeneca Pharmaceuticals LP4$87
Lilly USA, LLC5$87
GlaxoSmithKline, LLC.4$76
Bayer Healthcare Pharmaceuticals Inc.3$68
Inspire Medical Systems, Inc.1$61
Boehringer Ingelheim Pharmaceuticals, Inc.3$50

Products named: Veozah, TRELEGY ELLIPTA, Kerendia, JARDIANCE, AIRSUPRA, INSPIRE, OTEZLA, Ozempic.

Industry payments across MD — which companies pay providers there.